Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction
Circulation. Cardiovascular Interventions , Volume 7 - Issue 5 p. 673- 683
Background: Engraftment and survival of stem cells in the infarcted myocardium remain problematic in cell-based therapy for cardiovascular disease. To overcome these issues, encapsulated mesenchymal stem cells (eMSCs) were developed that were transfected to produce glucagon-like peptide-1, an incretin hormone with known cardioprotective effects, alongside MSC endogenous paracrine factors. This study was designed to investigate the efficacy of different doses of intracoronary infusion of eMSC in a porcine model of acute myocardial infarction (AMI). Methods and Results: One hundred pigs were subjected to a moderate AMI (posterolateral AMI; n=50) or a severe AMI (anterior AMI; n=50), whereupon surviving animals (n=36 moderate, n=33 severe) were randomized to receive eitherintracoronary infusion of 3 incremental doses of eMSC or Ringers' lactate control. Cardiac function was assessed using invasive hemodynamics, echocardiography, and histological analysis. A trend was observed in the moderate AMI model, whereas in the severe AMI model, left ventricular ejection fraction improved by +9.3% (P=0.004) in the best responding eMSC group, because of a preservation of left ventricular end-systolic volume. Arteriolar density increased 3-fold in the infarct area (8.4±0.9/mm<inf>2</inf> in controls versus 22.2±2.6/mm<inf>2</inf> in eMSC group; P<0.001). Although not statistically significant, capillary density was 30% higher in the border zone (908.1±99.7/mm<inf>2</inf> in control versus 1209.0±64.6/mm<inf>2</inf> in eMSC group; P=ns).. Conclusions-eMSCs enable sustained local delivery of cardioprotective proteins to the heart, thereby enhancing angiogenesis and preserving contractile function in an animal AMI model..
|Acute anterior wall myocardial infarction, Acute myocardial infarction, Cell therapy, Glucagon-like peptide-1, Mesenchymal stromal cells, Percutaneous coronary intervention|
|Circulation. Cardiovascular Interventions|
|Organisation||Department of Cardiology|
Jong, R, van Hout, G.P.J, Houtgraaf, H.J, Kazemi, K, Wallrapp, C, Lewis, A.L, … Duckers, H.J. (2014). Intracoronary infusion of encapsulated glucagon-like peptide-1-eluting mesenchymal stem cells preserves left ventricular function in a porcine model of acute myocardial infarction. Circulation. Cardiovascular Interventions, 7(5), 673–683. doi:10.1161/CIRCINTERVENTIONS.114.001580